NEVIRAPINE

NEVIRAPINE was reported 8991 times

NEVIRAPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRISOMY 17 10 0.7692
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 81 0.6279
2 ULTRASOUND ANTENATAL SCREEN 50 0.5208
3 CONJUNCTIVALISATION 16 0.5000
4 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 124 0.4460
5 RETROPERITONEAL DISORDER 10 0.4348
6 SPINOCEREBELLAR DISORDER 18 0.3830
7 PERITONEAL THICKENING 10 0.3571
8 PINEALOBLASTOMA 33 0.3548
9 CONGENITAL TUBERCULOSIS 4 0.3333
10 UVEAL PROLAPSE 7 0.3182
11 IMMUNODEFICIENCY CONGENITAL 7 0.2800
12 DIAPHRAGMATIC APLASIA 6 0.2308
13 POSTPARTUM SEPSIS 13 0.2281
14 DANDY-WALKER SYNDROME 56 0.2162
15 GENETIC POLYMORPHISM 12 0.2105
16 KWASHIORKOR 5 0.2083
17 HEPATIC DISPLACEMENT 5 0.2083
18 CEREBRAL MALARIA 5 0.2000
19 SUPERNUMERARY NIPPLE 16 0.1951
20 MITOCHONDRIAL TOXICITY 160 0.1949
21 VIRAL MUTATION IDENTIFIED 696 0.1888
22 ASTROCYTOMA MALIGNANT 19 0.1845
23 AIDS RELATED COMPLICATION 11 0.1692
24 FOETAL EXPOSURE DURING DELIVERY 112 0.1652
25 PREMATURE CLOSURE OF CRANIAL SUTURES 6 0.1579
26 VIROLOGIC FAILURE 800 0.1486
27 CONGENITAL NEOPLASM 4 0.1481
28 LIPODYSTROPHY ACQUIRED 314 0.1478
29 HIV INFECTION 432 0.1432
30 FLOPPY EYELID SYNDROME 5 0.1429
31 IMMUNE RECONSTITUTION SYNDROME 175 0.1356
32 CONGENITAL NAEVUS 19 0.1338
33 EYELID SCAR 5 0.1316
34 CONGENITAL HIV INFECTION 5 0.1282
35 VERTICAL INFECTION TRANSMISSION 14 0.1239
36 ACOUSTIC STIMULATION TESTS ABNORMAL 19 0.1218
37 IMMUNE RECOVERY UVEITIS 7 0.1207
38 BRACHYDACTYLY 22 0.1117
39 CONGENITAL DIAPHRAGMATIC ANOMALY 4 0.1111
40 EPIPHYSES DELAYED FUSION 6 0.1091
41 CARDIAC MALPOSITION 8 0.1053
42 CASTLEMAN'S DISEASE 6 0.1034
43 BORDERLINE LEPROSY 4 0.1026
44 THYMUS ENLARGEMENT 16 0.1000
45 TRISOMY 18 36 0.0945
46 HIV ANTIBODY POSITIVE 5 0.0926
47 TUBERCULOID LEPROSY 6 0.0923
48 MITOCHONDRIAL MYOPATHY 20 0.0917
49 RETINOBLASTOMA 10 0.0917
50 DEXTROCARDIA 17 0.0904
51 MEDIASTINAL SHIFT 6 0.0896
52 AIDS ENCEPHALOPATHY 5 0.0862
53 SYNOSTOSIS 9 0.0857
54 MACROCEPHALY 32 0.0825
55 HIV TEST POSITIVE 51 0.0772
56 LOW SET EARS 30 0.0730
57 HYDROPS FOETALIS 44 0.0718
58 LARYNGOMALACIA 22 0.0657
59 NODULAR REGENERATIVE HYPERPLASIA 41 0.0639
60 MATERNAL CONDITION AFFECTING FOETUS 14 0.0633
61 CONGENITAL PNEUMONIA 6 0.0632
62 ANGIOLIPOMA 4 0.0625
63 CEREBELLAR HYPOPLASIA 10 0.0595
64 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 19 0.0567
65 ENCEPHALOCELE 14 0.0562
66 BLADDER AGENESIS 4 0.0541
67 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 57 0.0527
68 CSF HIV ESCAPE SYNDROME 7 0.0507
69 KAPOSI'S SARCOMA 25 0.0498
70 BRACHYCEPHALY 5 0.0495
71 POLYDACTYLY 56 0.0483
72 CONGENITAL UMBILICAL HERNIA 18 0.0483
73 BLOOD HIV RNA INCREASED 86 0.0474
74 NEURODEVELOPMENTAL DISORDER 31 0.0459
75 RENAL ANEURYSM 11 0.0458
76 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 5 0.0450
77 ATRIOVENTRICULAR SEPTAL DEFECT 21 0.0447
78 NEUTROPENIA NEONATAL 10 0.0446
79 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 8 0.0440
80 PATHOGEN RESISTANCE 387 0.0424
81 SYMBLEPHARON 11 0.0421
82 EYELID PTOSIS CONGENITAL 4 0.0421
83 EPENDYMOMA 6 0.0414
84 PORTAL HYPERTENSIVE GASTROPATHY 23 0.0408
85 ACUTE HIV INFECTION 10 0.0405
86 DRUG RESISTANCE 1033 0.0402
87 RENAL DYSPLASIA 15 0.0388
88 VANISHING BILE DUCT SYNDROME 43 0.0386
89 ACQUIRED GENE MUTATION 50 0.0381
90 HIV VIRAEMIA 8 0.0381
91 EXPOSURE DURING BREAST FEEDING 125 0.0377
92 TRISOMY 21 47 0.0373
93 CHORIOAMNIONITIS 7 0.0368
94 MENINGOMYELOCELE 22 0.0367
95 MALARIA 25 0.0355
96 CD4 LYMPHOCYTES INCREASED 8 0.0343
97 LEFT VENTRICULAR DILATATION 17 0.0333
98 ACQUIRED IMMUNODEFICIENCY SYNDROME 17 0.0328
99 EXTRAOCULAR MUSCLE PARESIS 15 0.0327
100 OPHTHALMOPLEGIA 50 0.0317
101 CLEFT LIP AND PALATE 35 0.0313
102 DEFORMITY THORAX 6 0.0311
103 CONGENITAL EYELID MALFORMATION 4 0.0310
104 CONGENITAL GENITOURINARY ABNORMALITY 5 0.0309
105 PORTAL VENOUS GAS 11 0.0303
106 DEATH NEONATAL 42 0.0302
107 GENOTYPE DRUG RESISTANCE TEST POSITIVE 31 0.0302
108 PORTAL HYPERTENSION 90 0.0292
109 SPEECH DISORDER DEVELOPMENTAL 83 0.0289
110 BIRTH MARK 6 0.0288
111 LEPROSY 6 0.0288
112 MESENTERIC ARTERY THROMBOSIS 11 0.0286
113 VENTRICULAR ENLARGEMENT 5 0.0284
114 LIPOATROPHY 27 0.0284
115 STILLBIRTH 135 0.0279
116 ICHTHYOSIS 7 0.0278
117 BLEEDING VARICOSE VEIN 15 0.0277
118 CONGENITAL HYDROCEPHALUS 14 0.0276
119 FACIAL DYSMORPHISM 6 0.0271
120 NON-ALCOHOLIC FATTY LIVER 9 0.0267
121 BONE METABOLISM DISORDER 8 0.0266
122 GASTRITIS ATROPHIC 4 0.0265
123 MULTIPLE-DRUG RESISTANCE 82 0.0264
124 GENITAL LESION 11 0.0259
125 FAT REDISTRIBUTION 6 0.0259
126 VOLVULUS 59 0.0249
127 BIOPSY LIVER ABNORMAL 7 0.0233
128 SPINA BIFIDA 48 0.0230
129 PULMONARY HYPOPLASIA 18 0.0228
130 UPPER MOTOR NEURONE LESION 5 0.0227
131 CORNEAL LESION 7 0.0227
132 SUDDEN INFANT DEATH SYNDROME 11 0.0224
133 SEPSIS NEONATAL 18 0.0222
134 GENE MUTATION 43 0.0217
135 PNEUMOCYSTIS JIROVECI INFECTION 6 0.0217
136 HYPERTELORISM OF ORBIT 9 0.0215
137 MENINGITIS TUBERCULOUS 12 0.0215
138 FRACTURE MALUNION 4 0.0206
139 INTRA-UTERINE DEATH 33 0.0205
140 INFECTIVE ANEURYSM 10 0.0202
141 CUSHING'S SYNDROME 14 0.0201
142 CONGESTIVE HEPATOPATHY 9 0.0201
143 CHOLESTASIS OF PREGNANCY 9 0.0196
144 MENINGITIS CRYPTOCOCCAL 34 0.0194
145 CD4 LYMPHOCYTES DECREASED 41 0.0191
146 ANOMALY OF EXTERNAL EAR CONGENITAL 6 0.0190
147 CONGENITAL NOSE MALFORMATION 10 0.0188
148 VENTRICULAR SEPTAL DEFECT 107 0.0187
149 CYSTITIS NONINFECTIVE 25 0.0186
150 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 5 0.0185
151 BONE TUBERCULOSIS 7 0.0183
152 HYPERLACTACIDAEMIA 49 0.0183
153 MITOCHONDRIAL CYTOPATHY 8 0.0182
154 AMNIOTIC CAVITY INFECTION 13 0.0180
155 HELLP SYNDROME 11 0.0179
156 LIVER TENDERNESS 5 0.0179
157 ANENCEPHALY 10 0.0177
158 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 87 0.0174
159 PLACENTAL INSUFFICIENCY 14 0.0174
160 NEONATAL INFECTION 6 0.0173
161 FALLOT'S TETRALOGY 6 0.0173
162 PORTAL VEIN THROMBOSIS 55 0.0170
163 EYELID PTOSIS 168 0.0165
164 FOETAL DISTRESS SYNDROME 35 0.0165
165 GLYCOSURIA 22 0.0163
166 PORPHYRIA NON-ACUTE 7 0.0161
167 FAT TISSUE INCREASED 23 0.0159
168 VIRAL LOAD INCREASED 61 0.0157
169 NEONATAL ASPHYXIA 11 0.0155
170 NEUROSIS 7 0.0155
171 NEONATAL ASPIRATION 5 0.0152
172 EXOMPHALOS 8 0.0149
173 FACIAL WASTING 4 0.0149
174 BLOOD TRIGLYCERIDES DECREASED 5 0.0148
175 MOLLUSCUM CONTAGIOSUM 8 0.0148
176 ANAEMIA NEONATAL 7 0.0145
177 PREMATURE RUPTURE OF MEMBRANES 35 0.0145
178 MENTAL RETARDATION 5 0.0142
179 HEPATITIS C VIRUS 8 0.0142
180 SKULL MALFORMATION 9 0.0140
181 FOETAL EXPOSURE DURING PREGNANCY 1130 0.0139
182 CAESAREAN SECTION 161 0.0138
183 PROTRUSION TONGUE 8 0.0137
184 MICROALBUMINURIA 10 0.0132
185 EPIPHYSES PREMATURE FUSION 4 0.0132
186 CONGENITAL CHOROID PLEXUS CYST 4 0.0131
187 MATERNAL DRUGS AFFECTING FOETUS 100 0.0130
188 EAR MALFORMATION 6 0.0130
189 OESOPHAGEAL VARICES HAEMORRHAGE 28 0.0129
190 JOINT HYPEREXTENSION 5 0.0128
191 DRUG EXPOSURE VIA BREAST MILK 14 0.0128
192 FANCONI SYNDROME 18 0.0127
193 CRANIOSYNOSTOSIS 11 0.0127
194 ABDOMINAL SEPSIS 11 0.0125
195 EXTRAOCULAR MUSCLE DISORDER 4 0.0124
196 SYPHILIS 9 0.0124
197 NEURAL TUBE DEFECT 9 0.0124
198 ANAL CANCER 12 0.0124
199 VARICES OESOPHAGEAL 37 0.0122
200 HYPERSPLENISM 6 0.0121
201 MATERNAL EXPOSURE DURING DELIVERY 12 0.0121
202 TOXOPLASMOSIS 13 0.0120
203 DYSLIPIDAEMIA 61 0.0120
204 PRE-ECLAMPSIA 57 0.0120
205 INDUCED LABOUR 7 0.0117
206 SMALL FOR DATES BABY 58 0.0117
207 PLACENTAL DISORDER 11 0.0116
208 NEONATAL DISORDER 18 0.0114
209 CEREBRAL VENTRICLE DILATATION 13 0.0113
210 PNEUMOCYSTIS JIROVECI PNEUMONIA 25 0.0112
211 BRAIN MALFORMATION 4 0.0112
212 LYMPHADENITIS 27 0.0111
213 BRAIN HERNIATION 33 0.0110
214 CRYPTOCOCCOSIS 18 0.0110
215 NECROTISING RETINITIS 7 0.0109
216 RETINAL VASCULITIS 13 0.0109
217 FANCONI SYNDROME ACQUIRED 19 0.0108
218 DEVELOPMENTAL DELAY 97 0.0107
219 GASTRIC VARICES 5 0.0106
220 HEPATIC FIBROSIS 36 0.0105
221 BLOOD LACTIC ACID INCREASED 55 0.0104
222 PLEOCYTOSIS 6 0.0103
223 CYTOMEGALOVIRUS CHORIORETINITIS 20 0.0102
224 ASTROCYTOMA 4 0.0101
225 CHRONIC HEPATITIS 8 0.0099
226 PULMONARY TUBERCULOSIS 42 0.0098
227 LIPIDS ABNORMAL 7 0.0097
228 POSTPARTUM HAEMORRHAGE 13 0.0096
229 DELUSIONAL PERCEPTION 4 0.0096
230 HEPATOBILIARY DISEASE 6 0.0096
231 LOW BIRTH WEIGHT BABY 76 0.0096
232 ULCERATIVE KERATITIS 26 0.0095
233 CONVULSION NEONATAL 5 0.0095
234 DIABETIC HYPEROSMOLAR COMA 4 0.0093
235 DRUG EXPOSURE DURING PREGNANCY 315 0.0093
236 DISSEMINATED CRYPTOCOCCOSIS 7 0.0092
237 BLOOD TRIGLYCERIDES ABNORMAL 8 0.0091
238 DELIVERY 6 0.0091
239 GENITAL RASH 13 0.0091
240 EXPOSURE VIA BREAST MILK 36 0.0090
241 RENAL INFARCT 13 0.0090
242 HEPATOSPLENOMEGALY 23 0.0090
243 INTRACRANIAL HAEMATOMA 5 0.0089
244 LIMB MALFORMATION 7 0.0089
245 GASTROINTESTINAL STENOSIS 4 0.0088
246 BLOOD AMYLASE INCREASED 15 0.0088
247 PREMATURE BABY 260 0.0086
248 STEVENS-JOHNSON SYNDROME 192 0.0086
249 PANCREATITIS RELAPSING 7 0.0086
250 SJS-TEN OVERLAP 6 0.0085
251 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
252 NON-HODGKIN'S LYMPHOMA 11 0.0084
253 GASTROSCHISIS 4 0.0084
254 OLIGOHYDRAMNIOS 28 0.0084
255 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 5 0.0083
256 VISCERAL LEISHMANIASIS 6 0.0083
257 BLOOD VISCOSITY INCREASED 5 0.0083
258 DEAFNESS BILATERAL 14 0.0082
259 LIPOHYPERTROPHY 5 0.0080
260 CSF TEST ABNORMAL 4 0.0080
261 VIRAEMIA 11 0.0079
262 INSULIN RESISTANCE 16 0.0077
263 FOETAL GROWTH RETARDATION 6 0.0077
264 HEPATOTOXICITY 170 0.0076
265 HEPATITIS B 46 0.0076
266 SCLERAL DISCOLOURATION 5 0.0076
267 EXPOSURE DURING PREGNANCY 465 0.0075
268 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 5 0.0074
269 CONJUNCTIVAL HYPERAEMIA 26 0.0073
270 RED BLOOD CELL ABNORMALITY 7 0.0073
271 DYSMORPHISM 17 0.0072
272 PREMATURE SEPARATION OF PLACENTA 11 0.0071
273 PREMATURE LABOUR 40 0.0071
274 DISSEMINATED TUBERCULOSIS 18 0.0070
275 PREMATURE DELIVERY 111 0.0070
276 LYMPHOCYTIC INFILTRATION 7 0.0069
277 ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 0.0069
278 BREAST DISORDER 14 0.0069
279 ANOGENITAL WARTS 6 0.0067
280 GINGIVAL HYPERPLASIA 4 0.0067
281 PROTEIN URINE 6 0.0066
282 GENITAL ULCERATION 5 0.0065
283 CEREBRAL TOXOPLASMOSIS 6 0.0064
284 BLOOD KETONE BODY INCREASED 5 0.0064
285 PNEUMONIA STREPTOCOCCAL 7 0.0064
286 INJECTION SITE ULCER 6 0.0064
287 HYPERTRIGLYCERIDAEMIA 37 0.0063
288 SPUTUM CULTURE POSITIVE 5 0.0062
289 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 20 0.0062
290 TOXIC EPIDERMAL NECROLYSIS 93 0.0061
291 ANAEMIA MACROCYTIC 13 0.0061
292 FOETAL GROWTH RESTRICTION 37 0.0061
293 FOLATE DEFICIENCY 7 0.0061
294 MACROCYTOSIS 7 0.0060
295 CSF PROTEIN INCREASED 5 0.0060
296 CACHEXIA 31 0.0060
297 HEPATOMEGALY 59 0.0060
298 ANION GAP INCREASED 8 0.0060
299 CONGENITAL CYSTIC KIDNEY DISEASE 5 0.0059
300 CONJUNCTIVAL OEDEMA 6 0.0058
301 CEREBRAL CYST 4 0.0058
302 SKIN TOXICITY 32 0.0057
303 ALPHA 1 FOETOPROTEIN INCREASED 4 0.0056
304 JOINT CONTRACTURE 6 0.0056
305 FOETAL DEATH 29 0.0056
306 MUCOSAL EROSION 5 0.0055
307 DIPLOPIA 142 0.0055
308 ADENOCARCINOMA PANCREAS 7 0.0054
309 EXTENSOR PLANTAR RESPONSE 5 0.0054
310 CONGENITAL ANOMALY 42 0.0054
311 ATRIAL SEPTAL DEFECT 45 0.0054
312 JAUNDICE NEONATAL 10 0.0053
313 DILATATION VENTRICULAR 11 0.0052
314 OSTEOPOROTIC FRACTURE 10 0.0052
315 CLEFT PALATE 10 0.0052
316 EXOPHTHALMOS 11 0.0051
317 GLOMERULONEPHRITIS MEMBRANOUS 6 0.0051
318 STREPTOCOCCAL SEPSIS 6 0.0051
319 PREGNANCY 98 0.0049
320 OPPORTUNISTIC INFECTION 9 0.0049
321 MULTIPLE CONGENITAL ABNORMALITIES 7 0.0049
322 MYCOBACTERIUM AVIUM COMPLEX INFECTION 13 0.0048
323 BLOOD UREA DECREASED 6 0.0048
324 ADRENAL SUPPRESSION 4 0.0047
325 APRAXIA 7 0.0047
326 HEPATIC CYTOLYSIS 60 0.0047
327 PELVIC INFLAMMATORY DISEASE 7 0.0047
328 CEREBRAL ISCHAEMIA 24 0.0047
329 NEPHROPATHY TOXIC 52 0.0046
330 RENAL TUBULAR DISORDER 13 0.0046
331 PSYCHIATRIC DECOMPENSATION 9 0.0046
332 FOETAL MALFORMATION 5 0.0046
333 NORMAL NEWBORN 25 0.0046
334 AXONAL NEUROPATHY 4 0.0046
335 MULTI-ORGAN DISORDER 9 0.0046
336 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 5 0.0045
337 HEPATOCELLULAR DAMAGE 10 0.0044
338 ABORTION SPONTANEOUS 176 0.0044
339 GASTROENTERITIS 64 0.0044
340 CARBON DIOXIDE DECREASED 5 0.0043
341 METABOLIC SYNDROME 7 0.0043
342 HEPATITIS TOXIC 11 0.0042
343 ARNOLD-CHIARI MALFORMATION 4 0.0042
344 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 34 0.0041
345 EPIDERMAL NECROSIS 4 0.0041
346 GAZE PALSY 7 0.0041
347 STRABISMUS 12 0.0041
348 TREATMENT FAILURE 336 0.0041
349 RETINITIS 7 0.0040
350 OESOPHAGEAL CANDIDIASIS 16 0.0040
351 TROPONIN T INCREASED 5 0.0039
352 OSTEOMALACIA 6 0.0039
353 TALIPES 12 0.0039
354 LIVE BIRTH 32 0.0038
355 ABORTION INDUCED 36 0.0038
356 BRONCHOPNEUMONIA 13 0.0038
357 DERMATITIS EXFOLIATIVE GENERALISED 13 0.0037
358 BLOOD BICARBONATE DECREASED 7 0.0037
359 ACUTE PSYCHOSIS 9 0.0036
360 LACTIC ACIDOSIS 117 0.0036
361 DERMATITIS EXFOLIATIVE 18 0.0036
362 ECTOPIC PREGNANCY 11 0.0036
363 RENAL COLIC 8 0.0035
364 MYCOBACTERIAL INFECTION 6 0.0035
365 HEPATITIS C 42 0.0035
366 HOMICIDAL IDEATION 14 0.0034
367 HEPATIC NECROSIS 13 0.0034
368 ASPARTATE AMINOTRANSFERASE INCREASED 183 0.0034
369 UMBILICAL HERNIA 16 0.0034
370 ALANINE AMINOTRANSFERASE INCREASED 210 0.0034
371 ATAXIA 40 0.0034
372 SUSPECTED COVID-19 11 0.0033
373 BLOOD IMMUNOGLOBULIN G INCREASED 4 0.0033
374 HEPATITIS 84 0.0033
375 LIPASE INCREASED 25 0.0033
376 CALCULUS URINARY 5 0.0032
377 RASH MACULO-PAPULAR 72 0.0032
378 SPLENOMEGALY 37 0.0032
379 PROTEINURIA 60 0.0032
380 TINEA PEDIS 5 0.0031
381 TOTAL LUNG CAPACITY DECREASED 5 0.0031
382 JC VIRUS INFECTION 5 0.0031
383 ORAL CANDIDIASIS 41 0.0031
384 CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0031
385 SEBORRHOEIC DERMATITIS 5 0.0030
386 QUADRIPARESIS 5 0.0030
387 CYTOLYTIC HEPATITIS 10 0.0030
388 MENINGITIS 20 0.0030
389 NEPHROTIC SYNDROME 20 0.0029
390 FAILURE TO THRIVE 15 0.0029
391 MATERNAL EXPOSURE DURING PREGNANCY 256 0.0029
392 HYPOPHOSPHATAEMIA 21 0.0028
393 PANCREATIC FAILURE 5 0.0028
394 NEONATAL RESPIRATORY DISTRESS SYNDROME 10 0.0028
395 HEPATIC FAILURE 85 0.0028
396 PROCEDURAL HAEMORRHAGE 11 0.0028
397 GAMMA-GLUTAMYLTRANSFERASE INCREASED 62 0.0028
398 EOSINOPHILIA 49 0.0028
399 METABOLIC DISORDER 16 0.0028
400 SOFT TISSUE INFECTION 5 0.0027
401 TUMOUR LYSIS SYNDROME 24 0.0027
402 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
403 GROWTH RETARDATION 8 0.0027
404 PNEUMOPERITONEUM 5 0.0027
405 OTOTOXICITY 5 0.0027
406 HEPATITIS FULMINANT 8 0.0027
407 HEPATIC STEATOSIS 50 0.0027
408 METABOLIC ENCEPHALOPATHY 8 0.0027
409 CONGESTIVE CARDIOMYOPATHY 11 0.0026
410 AUTOIMMUNE HAEMOLYTIC ANAEMIA 9 0.0026
411 HYDROCEPHALUS 14 0.0026
412 ENDOPHTHALMITIS 15 0.0025
413 DRUG TOXICITY 34 0.0025
414 HYPERCHOLESTEROLAEMIA 24 0.0025
415 BLOOD BILIRUBIN INCREASED 66 0.0024
416 TREATMENT NONCOMPLIANCE 133 0.0024
417 DERMATITIS ALLERGIC 30 0.0024
418 JAUNDICE 64 0.0024
419 CREPITATIONS 7 0.0023
420 BLOOD PH DECREASED 4 0.0023
421 LYMPHOCYTOSIS 5 0.0023
422 HERPES SIMPLEX 15 0.0023
423 NEUROLOGICAL SYMPTOM 13 0.0023
424 BLOOD SODIUM INCREASED 6 0.0022
425 IRIDOCYCLITIS 7 0.0022
426 GRAND MAL CONVULSION 20 0.0022
427 RASH MORBILLIFORM 6 0.0022
428 LEUKOENCEPHALOPATHY 8 0.0021
429 HEPATIC ENCEPHALOPATHY 20 0.0021
430 BILIRUBIN CONJUGATED INCREASED 5 0.0021
431 VITILIGO 5 0.0021
432 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
433 ASCITES 61 0.0021
434 MALNUTRITION 23 0.0021
435 BLOOD CREATININE ABNORMAL 7 0.0020
436 TACHYPHRENIA 7 0.0020
437 HYPERREFLEXIA 7 0.0020
438 PROTEIN URINE PRESENT 10 0.0020
439 CAROTID ARTERY STENOSIS 7 0.0020
440 INTESTINAL ISCHAEMIA 11 0.0020
441 EMBOLISM VENOUS 6 0.0020
442 LYMPHADENOPATHY 70 0.0020
443 RESPIRATORY DISTRESS 53 0.0019
444 HEPATIC CIRRHOSIS 36 0.0019
445 BLOOD PHOSPHORUS DECREASED 7 0.0019
446 OSTEOPENIA 29 0.0019
447 HYPERSENSITIVITY VASCULITIS 5 0.0019
448 ACUTE HEPATIC FAILURE 26 0.0019
449 PARADOXICAL DRUG REACTION 7 0.0019
450 COLITIS MICROSCOPIC 9 0.0019
451 PSYCHIATRIC SYMPTOM 14 0.0019
452 NASAL DISORDER 5 0.0019
453 AREFLEXIA 5 0.0019
454 OCULAR ICTERUS 8 0.0018
455 ODYNOPHAGIA 11 0.0018
456 CERVICAL DYSPLASIA 4 0.0018
457 CEREBELLAR SYNDROME 4 0.0018
458 ORAL DISORDER 13 0.0018
459 ANAEMIA 335 0.0018
460 DRUG-INDUCED LIVER INJURY 55 0.0018
461 DRUG LEVEL INCREASED 29 0.0018
462 CANDIDIASIS 7 0.0017
463 ARTERIOSPASM CORONARY 7 0.0017
464 BLOOD CHOLESTEROL ABNORMAL 8 0.0017
465 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
466 DUODENITIS 5 0.0016
467 TACHYPNOEA 22 0.0016
468 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
469 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 41 0.0016
470 ENCEPHALITIS 11 0.0016
471 BRAIN ABSCESS 4 0.0016
472 HEPATOCELLULAR CARCINOMA 12 0.0016
473 HERPES VIRUS INFECTION 9 0.0016
474 EYELID OEDEMA 18 0.0015
475 HEPATITIS ACUTE 10 0.0015
476 CERVIX CARCINOMA 6 0.0015
477 PALLOR 41 0.0015
478 NERVOUS SYSTEM DISORDER 47 0.0015
479 HYPERPHAGIA 6 0.0015
480 CARDIAC MURMUR 13 0.0015
481 BLOOD CREATININE INCREASED 98 0.0015
482 CEREBRAL DISORDER 11 0.0015
483 TRANSAMINASES INCREASED 33 0.0015
484 OSTEOPOROSIS 61 0.0015
485 CLUMSINESS 4 0.0015
486 HYPERBILIRUBINAEMIA 15 0.0014
487 LYMPHOEDEMA 10 0.0014
488 GRANULOMA 5 0.0014
489 LIVER FUNCTION TEST ABNORMAL 42 0.0014
490 ABSCESS 23 0.0014
491 INTRACRANIAL PRESSURE INCREASED 8 0.0014
492 WEIGHT FLUCTUATION 15 0.0014
493 MASS 20 0.0014
494 HAEMOLYSIS 11 0.0014
495 CARDIAC FAILURE CHRONIC 6 0.0014
496 ANOREXIA 18 0.0014
497 BLOOD ALBUMIN DECREASED 11 0.0014
498 ESCHERICHIA SEPSIS 4 0.0014
499 DRUG INTERACTION 214 0.0013
500 PAPILLOEDEMA 6 0.0013
501 CEREBROVASCULAR DISORDER 4 0.0013
502 ADRENAL INSUFFICIENCY 16 0.0013
503 INFARCTION 9 0.0013
504 HAEMODIALYSIS 11 0.0013
505 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
506 HYPOTONIA 13 0.0013
507 FIBROSIS 4 0.0013
508 BLOOD ALKALINE PHOSPHATASE INCREASED 32 0.0013
509 METABOLIC ACIDOSIS 41 0.0013
510 PAPULE 9 0.0013
511 DRUG LEVEL DECREASED 13 0.0013
512 MYOPATHY 11 0.0013
513 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
514 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
515 RENAL CYST 10 0.0013
516 HYPOVOLAEMIC SHOCK 6 0.0013
517 NEUROPATHY PERIPHERAL 119 0.0012
518 ANGIOPATHY 7 0.0012
519 MACULAR OEDEMA 7 0.0012
520 DERMATITIS BULLOUS 9 0.0012
521 MAJOR DEPRESSION 9 0.0012
522 PARKINSONISM 12 0.0012
523 BACTERIAL SEPSIS 4 0.0012
524 HYPERTONIA 7 0.0012
525 RALES 7 0.0012
526 ULCER 19 0.0012
527 PATHOLOGICAL FRACTURE 6 0.0012
528 ERYTHEMA MULTIFORME 11 0.0012
529 LUNG NEOPLASM 5 0.0012
530 PURULENT DISCHARGE 5 0.0012
531 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
532 HEPATITIS CHOLESTATIC 7 0.0012
533 HYPOALBUMINAEMIA 9 0.0012
534 PYELONEPHRITIS 10 0.0012
535 PULMONARY HYPERTENSION 24 0.0012
536 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
537 PARTIAL SEIZURES 6 0.0011
538 CARDIOMEGALY 14 0.0011
539 BONE EROSION 4 0.0011
540 CHOLANGITIS 7 0.0011
541 VITAMIN D DEFICIENCY 11 0.0011
542 PSYCHOTIC DISORDER 33 0.0011
543 CHOLESTASIS 21 0.0011
544 DYSPAREUNIA 5 0.0011
545 SPEECH DISORDER 57 0.0011
546 HYPERLIPIDAEMIA 13 0.0011
547 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
548 RENAL FAILURE ACUTE 46 0.0011
549 BLOOD TRIGLYCERIDES INCREASED 19 0.0011
550 IMMUNE SYSTEM DISORDER 14 0.0011
551 REBOUND EFFECT 12 0.0011
552 MITRAL VALVE INCOMPETENCE 12 0.0011
553 LIVER DISORDER 47 0.0011
554 AUTOIMMUNE THYROIDITIS 4 0.0011
555 GENERALISED ERYTHEMA 6 0.0011
556 GASTRIC INFECTION 4 0.0010
557 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
558 SUBCUTANEOUS ABSCESS 5 0.0010
559 HAEMORRHOIDAL HAEMORRHAGE 5 0.0010
560 TORSADE DE POINTES 8 0.0010
561 PANCREATIC DISORDER 5 0.0010
562 GLUCOSE TOLERANCE IMPAIRED 6 0.0010
563 HEMIPARESIS 17 0.0010
564 CEREBRAL ATROPHY 4 0.0010
565 CREATININE RENAL CLEARANCE DECREASED 4 0.0010
566 BLOOD DISORDER 8 0.0010
567 ERYSIPELAS 5 0.0010
568 LYMPHOPENIA 14 0.0010
569 ECONOMIC PROBLEM 15 0.0010
570 SKIN LESION 27 0.0010
571 APLASTIC ANAEMIA 5 0.0010
572 PYREXIA 330 0.0010
573 GASTRITIS 25 0.0009
574 OSTEONECROSIS 31 0.0009
575 HYDRONEPHROSIS 7 0.0009
576 SEPSIS 104 0.0009
577 END STAGE RENAL DISEASE 17 0.0009
578 BACTERAEMIA 11 0.0009
579 PLATELET COUNT INCREASED 12 0.0009
580 POLYNEUROPATHY 11 0.0009
581 CONJUNCTIVITIS 17 0.0009
582 ACIDOSIS 7 0.0009
583 SINUS TACHYCARDIA 13 0.0009
584 ANHEDONIA 24 0.0009
585 PANCREATITIS 48 0.0009
586 CYTOMEGALOVIRUS INFECTION REACTIVATION 4 0.0009
587 DRUG ERUPTION 16 0.0009
588 NECROSIS 5 0.0009
589 HAEMOLYTIC ANAEMIA 8 0.0009
590 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
591 HAEMATURIA 30 0.0009
592 VISUAL ACUITY REDUCED 29 0.0009
593 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
594 BLOOD URIC ACID INCREASED 5 0.0009
595 AUTOIMMUNE HEPATITIS 6 0.0009
596 SKIN WARM 5 0.0009
597 ASPHYXIA 7 0.0009
598 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
599 ENCEPHALOPATHY 21 0.0009
600 SUDDEN DEATH 9 0.0008
601 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
602 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
603 BONE MARROW FAILURE 17 0.0008
604 SYNOVITIS 15 0.0008
605 CYANOSIS 13 0.0008
606 PANCYTOPENIA 46 0.0008
607 PERICARDIAL EFFUSION 19 0.0008
608 DYSPHAGIA 76 0.0008
609 DYSARTHRIA 30 0.0008
610 PERITONITIS BACTERIAL 8 0.0008
611 LUNG INFILTRATION 7 0.0008
612 VAGINAL DISCHARGE 8 0.0008
613 RESPIRATORY RATE INCREASED 7 0.0008
614 CHOLECYSTECTOMY 9 0.0008
615 AMMONIA INCREASED 4 0.0008
616 DELIRIUM 27 0.0008
617 LYMPHOMA 12 0.0008
618 RENAL IMPAIRMENT 65 0.0008
619 APHTHOUS ULCER 6 0.0008
620 PNEUMONIA BACTERIAL 7 0.0008
621 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
622 CORONAVIRUS INFECTION 5 0.0008
623 TRICUSPID VALVE INCOMPETENCE 6 0.0008
624 INTENTIONAL PRODUCT USE ISSUE 66 0.0008
625 NEPHROPATHY 7 0.0007
626 SKIN MASS 5 0.0007
627 ACUTE MYOCARDIAL INFARCTION 22 0.0007
628 GYNAECOMASTIA 23 0.0007
629 NEUROTOXICITY 13 0.0007
630 BLINDNESS 30 0.0007
631 HEPATIC ENZYME INCREASED 50 0.0007
632 POLYURIA 6 0.0007
633 CENTRAL NERVOUS SYSTEM LESION 10 0.0007
634 CYTOMEGALOVIRUS INFECTION 12 0.0007
635 FOOT DEFORMITY 8 0.0007
636 HEMIPLEGIA 6 0.0007
637 NEUTROPENIA 98 0.0007
638 COORDINATION ABNORMAL 10 0.0007
639 RENAL TUBULAR NECROSIS 7 0.0007
640 DELUSION 11 0.0007
641 RETINAL HAEMORRHAGE 5 0.0007
642 MULTI-ORGAN FAILURE 12 0.0007
643 PRURITUS GENERALISED 15 0.0007
644 PHOTOPHOBIA 13 0.0007
645 MENTAL DISORDER 30 0.0007
646 CARDIOMYOPATHY 10 0.0007
647 PETECHIAE 7 0.0007
648 GASTROINTESTINAL INFECTION 6 0.0007
649 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
650 HAEMOGLOBIN DECREASED 68 0.0007
651 DERMATITIS ACNEIFORM 4 0.0007
652 RASH GENERALISED 17 0.0007
653 HAEMATOCRIT DECREASED 13 0.0007
654 CONVULSION 37 0.0006
655 AGRANULOCYTOSIS 12 0.0006
656 PHARYNGITIS 8 0.0006
657 DIABETES MELLITUS 49 0.0006
658 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
659 BLOOD SODIUM DECREASED 12 0.0006
660 HYPOTHYROIDISM 20 0.0006
661 PANCREATITIS ACUTE 14 0.0006
662 MOUTH ULCERATION 13 0.0006
663 GASTROINTESTINAL DISORDER 55 0.0006
664 MYOCARDITIS 7 0.0006
665 DRUG WITHDRAWAL SYNDROME NEONATAL 9 0.0006
666 BONE DISORDER 11 0.0006
667 QUALITY OF LIFE DECREASED 8 0.0006
668 LUNG DISORDER 29 0.0006
669 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
670 BACTERIAL INFECTION 11 0.0006
671 MYOCLONUS 7 0.0006
672 HYPOKALAEMIA 27 0.0006
673 ERECTILE DYSFUNCTION 15 0.0006
674 DEATH 500 0.0006
675 THERAPY NON-RESPONDER 26 0.0006
676 RENAL FAILURE 76 0.0006
677 HYPOXIA 20 0.0006
678 HALLUCINATION, AUDITORY 9 0.0006
679 GENERALISED OEDEMA 7 0.0006
680 ACUTE KIDNEY INJURY 86 0.0006
681 DECREASED ACTIVITY 6 0.0006
682 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
683 BRAIN OEDEMA 7 0.0006
684 DEEP VEIN THROMBOSIS 36 0.0006
685 MUSCLE ATROPHY 7 0.0006
686 DISEASE RECURRENCE 26 0.0005
687 ABNORMAL DREAMS 15 0.0005
688 LOWER RESPIRATORY TRACT INFECTION 24 0.0005
689 MYALGIA 89 0.0005
690 NEOPLASM 6 0.0005
691 UVEITIS 7 0.0005
692 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
693 PULMONARY EMBOLISM 48 0.0005
694 TYPE 2 DIABETES MELLITUS 17 0.0005
695 PNEUMOTHORAX 8 0.0005
696 THROMBOCYTOPENIA 56 0.0005
697 NIGHT SWEATS 16 0.0005
698 BLINDNESS UNILATERAL 7 0.0005
699 HEPATOCELLULAR INJURY 7 0.0005
700 RENAL DISORDER 23 0.0005
701 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
702 ABNORMAL FAECES 4 0.0005
703 EYE DISORDER 16 0.0005
704 TOXICITY TO VARIOUS AGENTS 82 0.0005
705 RASH 211 0.0005
706 HEPATIC FUNCTION ABNORMAL 18 0.0005
707 EYE DISCHARGE 5 0.0005
708 DRUG ABUSE 40 0.0005
709 COAGULOPATHY 8 0.0005
710 FOOT FRACTURE 9 0.0005
711 JOINT DISLOCATION 5 0.0005
712 BLOOD CHOLESTEROL INCREASED 22 0.0005
713 FACIAL PARALYSIS 4 0.0005
714 VOMITING 220 0.0005
715 FEBRILE NEUTROPENIA 31 0.0005
716 DRUG INTOLERANCE 45 0.0005
717 BLOOD POTASSIUM DECREASED 14 0.0005
718 HYPOAESTHESIA ORAL 7 0.0005
719 NIGHTMARE 16 0.0005
720 DEAFNESS 12 0.0005
721 STAPHYLOCOCCAL INFECTION 15 0.0005
722 HEAD DISCOMFORT 8 0.0005
723 EYE HAEMORRHAGE 6 0.0004
724 MALIGNANT MELANOMA 6 0.0004
725 OCULAR DISCOMFORT 5 0.0004
726 BLOOD CALCIUM DECREASED 5 0.0004
727 CHROMATURIA 10 0.0004
728 ABDOMINAL PAIN 100 0.0004
729 VASCULITIS 5 0.0004
730 ABNORMAL BEHAVIOUR 17 0.0004
731 RASH MACULAR 15 0.0004
732 APPENDICITIS 4 0.0004
733 HALLUCINATION, VISUAL 9 0.0004
734 HYPONATRAEMIA 24 0.0004
735 RASH PRURITIC 23 0.0004
736 OEDEMA 23 0.0004
737 DRY EYE 21 0.0004
738 EYE INFLAMMATION 4 0.0004
739 PARALYSIS 6 0.0004
740 PNEUMONIA 135 0.0004
741 BONE DENSITY DECREASED 13 0.0004
742 HYPOKINESIA 6 0.0004
743 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
744 CIRCULATORY COLLAPSE 7 0.0004
745 LIVER INJURY 10 0.0004
746 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
747 TENDON RUPTURE 5 0.0004
748 LOCAL SWELLING 7 0.0004
749 LEUKOPENIA 20 0.0004
750 CORONARY ARTERY DISEASE 12 0.0004
751 HAEMATEMESIS 10 0.0004
752 HYPERTENSION 83 0.0004
753 AGITATION 28 0.0004
754 DEPRESSED MOOD 20 0.0004
755 RASH ERYTHEMATOUS 18 0.0004
756 WEIGHT DECREASED 105 0.0004
757 URINARY INCONTINENCE 11 0.0004
758 CHRONIC KIDNEY DISEASE 28 0.0004
759 ASPIRATION 4 0.0004
760 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
761 COGNITIVE DISORDER 17 0.0004
762 SEIZURE 42 0.0004
763 VENTRICULAR TACHYCARDIA 6 0.0004
764 VERTIGO 22 0.0004
765 THROMBOSIS 29 0.0004
766 SUICIDAL IDEATION 33 0.0004
767 HAEMOPTYSIS 10 0.0004
768 BLOOD UREA INCREASED 6 0.0004
769 C-REACTIVE PROTEIN INCREASED 13 0.0004
770 RASH PAPULAR 8 0.0004
771 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
772 FACE OEDEMA 6 0.0004
773 SKIN EXFOLIATION 30 0.0004
774 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
775 OEDEMA PERIPHERAL 43 0.0004
776 INFECTION 51 0.0004
777 RED BLOOD CELL COUNT DECREASED 10 0.0003
778 COUGH 98 0.0003
779 TACHYCARDIA 31 0.0003
780 CARDIAC FAILURE 28 0.0003
781 SKIN ULCER 9 0.0003
782 HERPES ZOSTER 20 0.0003
783 HYPERTHYROIDISM 5 0.0003
784 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
785 ELECTROLYTE IMBALANCE 4 0.0003
786 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
787 BLISTER 19 0.0003
788 GENERAL PHYSICAL HEALTH DETERIORATION 39 0.0003
789 MUSCULAR WEAKNESS 38 0.0003
790 RESPIRATORY DISORDER 10 0.0003
791 DRUG EFFECT DECREASED 18 0.0003
792 DERMATITIS 7 0.0003
793 IRRITABILITY 20 0.0003
794 LETHARGY 19 0.0003
795 SKIN DISORDER 11 0.0003
796 NEPHROLITHIASIS 15 0.0003
797 MUSCULOSKELETAL PAIN 17 0.0003
798 MENTAL STATUS CHANGES 9 0.0003
799 ABASIA 8 0.0003
800 HYPERSENSITIVITY 60 0.0003
801 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
802 SWELLING FACE 21 0.0003
803 CYST 4 0.0003
804 EXTRAPYRAMIDAL DISORDER 8 0.0003
805 MYOCARDIAL INFARCTION 56 0.0003
806 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
807 FLUID RETENTION 16 0.0003
808 OBESITY 5 0.0003
809 PULMONARY FIBROSIS 6 0.0003
810 PRODUCT SUBSTITUTION ISSUE 18 0.0003
811 PLEURAL EFFUSION 19 0.0003
812 DRUG INEFFECTIVE 406 0.0003
813 BLOOD POTASSIUM INCREASED 5 0.0003
814 CHOLELITHIASIS 10 0.0003
815 RESPIRATORY FAILURE 22 0.0003
816 PALPITATIONS 35 0.0003
817 SLEEP DISORDER 21 0.0003
818 DEHYDRATION 39 0.0003
819 MOBILITY DECREASED 21 0.0003
820 CORONARY ARTERY OCCLUSION 4 0.0003
821 CONFUSIONAL STATE 47 0.0003
822 RHABDOMYOLYSIS 12 0.0003
823 PLATELET COUNT DECREASED 30 0.0003
824 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
825 AGGRESSION 14 0.0003
826 HALLUCINATION 21 0.0003
827 DISTURBANCE IN ATTENTION 15 0.0003
828 SEPTIC SHOCK 12 0.0003
829 FLUID OVERLOAD 4 0.0003
830 ASTHENIA 103 0.0003
831 ACCIDENTAL OVERDOSE 10 0.0003
832 RESTLESSNESS 10 0.0003
833 ADVERSE EVENT 25 0.0003
834 DIARRHOEA 175 0.0003
835 BONE LOSS 4 0.0003
836 APHASIA 8 0.0003
837 SHOCK 6 0.0003
838 DEPRESSION 59 0.0003
839 DYSTONIA 5 0.0003
840 HYPERKALAEMIA 9 0.0003
841 HAEMORRHOIDS 5 0.0003
842 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
843 DECREASED APPETITE 58 0.0002
844 MOVEMENT DISORDER 8 0.0002
845 WHITE BLOOD CELL COUNT DECREASED 27 0.0002
846 HAEMORRHAGE 26 0.0002
847 ANGIOEDEMA 11 0.0002
848 EMOTIONAL DISTRESS 30 0.0002
849 MENTAL IMPAIRMENT 6 0.0002
850 HYPERGLYCAEMIA 9 0.0002
851 PULMONARY OEDEMA 11 0.0002
852 CEREBRAL INFARCTION 6 0.0002
853 RIB FRACTURE 5 0.0002
854 DRUG WITHDRAWAL SYNDROME 21 0.0002
855 DYSPNOEA EXERTIONAL 9 0.0002
856 HYPOPHAGIA 6 0.0002
857 EYE PAIN 13 0.0002
858 VAGINAL HAEMORRHAGE 10 0.0002
859 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
860 DYSKINESIA 9 0.0002
861 ABDOMINAL DISTENSION 23 0.0002
862 SOMNOLENCE 44 0.0002
863 TINNITUS 10 0.0002
864 MALAISE 95 0.0002
865 EYE SWELLING 8 0.0002
866 OXYGEN SATURATION DECREASED 12 0.0002
867 CHILLS 25 0.0002
868 INTESTINAL OBSTRUCTION 8 0.0002
869 PRODUCTIVE COUGH 10 0.0002
870 ANGINA PECTORIS 6 0.0002
871 EYE PRURITUS 7 0.0002
872 DIABETIC KETOACIDOSIS 5 0.0002
873 NAUSEA 164 0.0002
874 DISABILITY 4 0.0002
875 DYSPNOEA 114 0.0002
876 PNEUMONIA ASPIRATION 5 0.0002
877 ERYTHEMA 41 0.0002
878 CARDIAC FAILURE CONGESTIVE 16 0.0002
879 MEDICATION ERROR 11 0.0002
880 NEUTROPHIL COUNT DECREASED 8 0.0002
881 SKIN DISCOLOURATION 9 0.0002
882 BLOOD PRESSURE DECREASED 13 0.0002
883 CHEST DISCOMFORT 20 0.0002
884 HYPERHIDROSIS 25 0.0002
885 FLATULENCE 11 0.0002
886 PANIC ATTACK 7 0.0002
887 CARDIO-RESPIRATORY ARREST 8 0.0002
888 COMA 9 0.0002
889 EATING DISORDER 4 0.0002
890 CONDITION AGGRAVATED 57 0.0002
891 DYSPEPSIA 18 0.0002
892 VISION BLURRED 25 0.0002
893 HAEMATOCHEZIA 10 0.0002
894 DEMENTIA 5 0.0002
895 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
896 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
897 CHEST PAIN 32 0.0002
898 INTERSTITIAL LUNG DISEASE 8 0.0002
899 HYPOGLYCAEMIA 8 0.0002
900 THERAPEUTIC RESPONSE DECREASED 10 0.0002
901 DYSURIA 6 0.0002
902 EMOTIONAL DISORDER 5 0.0002
903 HYPOTENSION 32 0.0002
904 HEADACHE 99 0.0002
905 INSOMNIA 42 0.0002
906 FATIGUE 121 0.0002
907 ANAPHYLACTIC SHOCK 4 0.0002
908 ANXIETY 44 0.0002
909 PARAESTHESIA 24 0.0002
910 WEIGHT INCREASED 34 0.0002
911 DISORIENTATION 6 0.0002
912 CATARACT 9 0.0002
913 TREMOR 25 0.0002
914 ABDOMINAL PAIN UPPER 31 0.0002
915 NO ADVERSE EVENT 27 0.0001
916 STOMATITIS 9 0.0001
917 OVERDOSE 32 0.0001
918 GASTRIC DISORDER 5 0.0001
919 OFF LABEL USE 127 0.0001
920 DIZZINESS 70 0.0001
921 SWELLING 13 0.0001
922 AMNESIA 9 0.0001
923 CRYING 5 0.0001
924 INFLAMMATION 7 0.0001
925 ECZEMA 7 0.0001
926 PAIN IN EXTREMITY 39 0.0001
927 ARTHRALGIA 55 0.0001
928 ILL-DEFINED DISORDER 8 0.0001
929 EPILEPSY 4 0.0001
930 VISUAL IMPAIRMENT 16 0.0001
931 NECK PAIN 7 0.0001
932 INFLUENZA LIKE ILLNESS 10 0.0001
933 HEART RATE INCREASED 12 0.0001
934 NEOPLASM MALIGNANT 8 0.0001
935 PRURITUS 46 0.0001
936 BONE PAIN 7 0.0001
937 CELLULITIS 6 0.0001
938 THERAPY CESSATION 6 0.0001
939 HYPOAESTHESIA 17 0.0001
940 DRY MOUTH 9 0.0001
941 DISEASE PROGRESSION 13 0.0001
942 GAIT DISTURBANCE 21 0.0001
943 CEREBROVASCULAR ACCIDENT 18 0.0001
944 BLOOD GLUCOSE DECREASED 5 0.0001
945 DYSPHONIA 6 0.0001
946 BURNING SENSATION 7 0.0001
947 INJURY 7 0.0001
948 OROPHARYNGEAL PAIN 9 0.0001
949 CONSTIPATION 21 0.0001
950 DYSGEUSIA 7 0.0001
951 LOSS OF CONSCIOUSNESS 12 0.0001
952 UNEVALUABLE EVENT 7 0.0001
953 URTICARIA 15 0.0001
954 FALL 29 0.0001
955 COVID-19 15 0.0001
956 CARDIAC ARREST 7 0.0001
957 COMPLETED SUICIDE 7 0.0001
958 PAIN 51 0.0001
959 DISCOMFORT 5 0.0001
960 BRONCHITIS 6 0.0001
961 ADVERSE DRUG REACTION 7 0.0001
962 URINARY TRACT INFECTION 13 0.0001
963 DERMATITIS ATOPIC 4 0.0001
964 PRODUCT USE ISSUE 14 0.0001
965 BACK PAIN 16 0.0001
966 ABDOMINAL DISCOMFORT 11 0.0001
967 PERIPHERAL SWELLING 10 0.0001
968 BLOOD GLUCOSE INCREASED 12 0.0001
969 CONTUSION 6 0.0001
970 RHEUMATOID ARTHRITIS 7 0.0001
971 ALOPECIA 12 0.0001
972 MUSCLE SPASMS 11 0.0001
973 BLOOD PRESSURE INCREASED 9 0.0001
974 BALANCE DISORDER 5 0.0001
975 MUSCULOSKELETAL STIFFNESS 5 0.0001
976 EPISTAXIS 4 0.0001
977 ACNE 4 0.0001
978 INCORRECT DOSE ADMINISTERED 12 0.0001
979 FLUSHING 5 0.0000
980 ASTHMA 5 0.0000
981 CARDIAC DISORDER 4 0.0000
982 DRUG DOSE OMISSION 7 0.0000
983 FEELING ABNORMAL 10 0.0000
984 ATRIAL FIBRILLATION 4 0.0000
985 HOSPITALISATION 6 0.0000
986 PSORIASIS 5 0.0000
987 DRY SKIN 5 0.0000
988 MEMORY IMPAIRMENT 5 0.0000
989 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
991 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
992 PRODUCT DOSE OMISSION ISSUE 8 0.0000